H.R. 7346: John W. Walsh Alpha-1 Home Infusion Act of 2022
Before you vote › Federal bills
H.R. 7346: John W. Walsh Alpha-1 Home Infusion Act of 2022
117th Congress · introduced 2022-03-31 · Health · Latest: Referred to the Subcommittee on Health.
federal
Follow this bill, step by step
- Where it came from: introduced 2022-03-31 · official record
- Who proposed it: Rep. Salazar, Maria Elvira [R-FL-27] · what a sponsor is
- What happened next: no floor votes in our records yet. Why?
- Where it stands now: Referred to the Subcommittee on Health. Not final yet: this can still change. We check for updates every day.
- If it becomes law and spends money: follow the money to money laws, then agencies and contracts and grants.
Official title
John W. Walsh Alpha-1 Home Infusion Act of 2022
Plain summary
John W. Walsh Alpha-1 Home Infusion Act of 2022 This bill provides for Medicare coverage of treatment for alpha-1 antitrypsin (AAT) deficiency (a protein deficiency that raises the risk of lung and other diseases). Specifically, the bill provides for coverage of at-home augmentation therapy for beneficiaries with emphysema as a result of severe hereditary AAT deficiency. Treatment must be provided through qualified home infusion therapy suppliers; beneficiaries must be under the care of a physician, nurse practitioner, or physician assistant.
Congressional Research Service summary (Introduced in House), quoted unchanged (nonpartisan). Read the source.
What a vote does
A “Yea” vote
If it passes both chambers and is signed, it becomes law.
A “Nay” vote
If it is not passed, current law stays as it is.
PSI Sci description of the legislative step (not an opinion).
What does this mean? (plain words)
Official text
John W. Walsh Alpha-1 Home Infusion Act of 2022
Source: Congressional Research Service summary (Introduced in House)
AI explanation – may be wrong, check the official text
No AI explanation yet. It takes up to a minute to write and is then saved for everyone.
Limited to a few requests an hour per person.
The strongest published arguments
Arguments for (supporters)
Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.
Arguments against (opponents)
Needs sources: no published arguments on this side yet. We only show items backed by a published source. Suggest one.
Alternatives
Needs sources: no published alternatives yet (for example a different bill, a law instead of an amendment, or keeping current law). We only show items backed by a published source. Suggest one.
How did my representative vote? · This bill's floor votes
Officials and money
Sponsor: Rep. Salazar, Maria Elvira [R-FL-27] · 15 cosponsors
Cost estimate: No cost estimate published yet.
Cosponsors on this site
Chellie Pingree (D-ME), Debbie Wasserman Schultz (D-FL), Paul Tonko (D-NY), Jimmy Panetta (D-CA), Burgess Owens (R-UT), Mike Thompson (D-CA), William R. Keating (D-MA), Deborah K. Ross (D-NC), John B. Larson (D-CT)
Sponsor's campaign money: Rep. Salazar, Maria Elvira [R-FL-27] reported raising $2.5 million (2025–2026). Details. Shown for context only; it does not mean any donor supported this bill.
No linked floor roll calls in our collected records yet. This does not mean the bill has never had a vote. Check the official bill history.
Words on this page, explained (1)
- Bill
- A proposed law. It becomes law only if it passes the legislature and is signed by the president or governor (or a veto is overridden).
Plain meanings written from linked sources. All words.
Sources
- Congressional Research Service summary (Introduced in House)
- Congress.gov
- Data: GovInfo BILLSTATUS bulk data (Library of Congress), BILLSTATUS-117hr7346.xml <https://www.govinfo.gov/bulkdata/BILLSTATUS/117/hr>
Record fed-us-cong117-hr7346 · catalog fed-us-congress-bills-cong117 · updated 2026-11-15 by psicol fed-bills-cong117